USPTO, Wisconsin Alumni Research Foundation, Geron, GenVec, National Institute of Allergy and Infectious Diseases, Fred Hutchinson Cancer Research Center, University of Washington, NanoBio, Redpoint Bio, Mount Sinai School of Medicine, National University | GenomeWeb
USPTO Upholds Pair of WARF, Geron Stem Cell Patents
The US Patent and Trademark Office has upheld the validity of the two most important stem cell patents assigned to the Wisconsin Alumni Research Foundation and exclusively licensed by Geron, WARF and Geron said this week.
The USPTO specifically upheld US Patent Nos. 5,843,780 and 6,200,806, which respectively claim preparations of primate and human embryonic stem cells and methods for their isolation.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.